- Home
- APVO vs ALLR Comparison
APVO vs ALLR Comparison
Compare APVO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- ALLR
- Stock Information
- Founded
- APVO 2016
- ALLR 2004
- Country
- APVO United States
- ALLR United States
- Employees
- APVO N/A
- ALLR N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- APVO Health Care
- ALLR Health Care
- Exchange
- APVO Nasdaq
- ALLR Nasdaq
- Market Cap
- APVO 5.4M
- ALLR 6.0M
- IPO Year
- APVO N/A
- ALLR N/A
- Fundamental
- Price
- APVO $3.47
- ALLR $0.95
- Analyst Decision
- APVO Strong Buy
- ALLR
- Analyst Count
- APVO 1
- ALLR 0
- Target Price
- APVO $296.00
- ALLR N/A
- AVG Volume (30 Days)
- APVO 44.0K
- ALLR 2.3M
- Earning Date
- APVO 03-04-2025
- ALLR 03-07-2025
- Dividend Yield
- APVO N/A
- ALLR N/A
- EPS Growth
- APVO N/A
- ALLR N/A
- EPS
- APVO N/A
- ALLR N/A
- Revenue
- APVO N/A
- ALLR N/A
- Revenue This Year
- APVO N/A
- ALLR N/A
- Revenue Next Year
- APVO N/A
- ALLR N/A
- P/E Ratio
- APVO N/A
- ALLR N/A
- Revenue Growth
- APVO N/A
- ALLR N/A
- 52 Week Low
- APVO $3.01
- ALLR $0.90
- 52 Week High
- APVO $399.60
- ALLR $264.00
- Technical
- Relative Strength Index (RSI)
- APVO 33.42
- ALLR 40.42
- Support Level
- APVO $3.20
- ALLR $0.91
- Resistance Level
- APVO $3.65
- ALLR $1.03
- Average True Range (ATR)
- APVO 0.34
- ALLR 0.09
- MACD
- APVO 0.01
- ALLR -0.02
- Stochastic Oscillator
- APVO 31.51
- ALLR 13.88
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.